Skip to content
10-Q

Quarterly Report

Apyx Medical Corp APYX

0001437749-25-015356

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 37.79M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $34.13M
Long Term Debt Q1 2025 · Dec 31, 2024 $33.89M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $31.01M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $31.74M
Stockholders Equity Q1 2025 · Mar 31, 2025 $10.51M
Stockholders Equity Q1 2025 · Dec 31, 2024 $14.21M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.51M
Current Liabilities Q1 2025 · Dec 31, 2024 $10.72M
Total Liabilities Q1 2025 · Mar 31, 2025 $49.52M
Total Liabilities Q1 2025 · Dec 31, 2024 $50.51M
Current Assets Q1 2025 · Mar 31, 2025 $51.85M
Current Assets Q1 2025 · Dec 31, 2024 $56.44M
Total Assets Q1 2025 · Mar 31, 2025 $60.16M
Total Assets Q1 2025 · Dec 31, 2024 $64.84M
Capex Q1 2025 · Mar 31, 2024 $35K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.34M
Eps Basic Q1 2025 · Mar 31, 2024 −$0.22
Sga Expense Q1 2025 · Mar 31, 2024 $4.9M
Rd Expense Q1 2025 · Mar 31, 2024 $1.4M
Net Income Q1 2025 · Mar 31, 2024 −$7.58M
Operating Income Q1 2025 · Mar 31, 2024 −$6.62M
Gross Profit Q1 2025 · Mar 31, 2024 $5.95M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $4.3M
Revenue Q1 2025 · Mar 31, 2024 $10.24M